Literature DB >> 19470495

Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.

I E Muth1, K Barthel, M Bähr, M C Dalakas, J Schmidt.   

Abstract

BACKGROUND: In the pathology of sporadic inclusion body myositis (sIBM), the relevance of cell stress molecules such as the heat shock protein alphaB-crystallin, particularly in healthy appearing muscle fibres, has remained elusive.
METHODS: 10 muscle biopsies from sIBM patients were serially stained for haematoxylin-eosin, trichrome and multi-immunohistochemistry for neural cell adhesion molecule (NCAM), alphaB-crystallin, amyloid precursor protein (APP), desmin, major histocompatibility complex I, beta-amyloid and ubiquitin. Corresponding areas of all biopsies were quantitatively analysed for all markers. Primary myotube cultures were exposed to the proinflammatory cytokines interleukin (IL)-1beta and interferon (IFN)-gamma.
RESULTS: In human myotubes exposed to IL-1beta+IFN-gamma, overexpression of APP was accompanied by upregulation of alphaB-crystallin. In sIBM muscle biopsies, over 20% of all fibres displayed accumulation of beta-amyloid or vacuoles/inclusions. A clearly larger fraction of the fibres were positive for alphaB-crystallin or APP. In contrast with the accumulation of beta-amyloid in atrophic fibres, a major part of fibres positive for APP or alphaB-crystallin showed no morphological abnormalities. Expression of APP and alphaB-crystallin significantly correlated with each other and most double positive fibres displayed accumulation of beta-amyloid, vacuoles or an atrophic morphology. In almost all of these fibres, other markers of degeneration/regeneration such as NCAM and desmin were evident as additional indicators of a cell stress response. Some fibres double positive for APP and alphaB-crystallin displayed infiltration by inflammatory cells.
CONCLUSION: Our results suggest that alphaB-crystallin is associated with overexpression of APP in sIBM muscle and that upregulation of alphaB-crystallin precedes accumulation of beta-amyloid. The data help to better understand early pathological changes and underscore the fact that a network of cell stress, inflammation and degeneration is relevant to sIBM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470495     DOI: 10.1136/jnnp.2009.174276

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Crystallins and neuroinflammation: The glial side of the story.

Authors:  Jennifer E Dulle; Patrice E Fort
Journal:  Biochim Biophys Acta       Date:  2015-06-03

2.  Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.

Authors:  Anne-Katrin Güttsches; Stefen Brady; Kathryn Krause; Alexandra Maerkens; Julian Uszkoreit; Martin Eisenacher; Anja Schreiner; Sara Galozzi; Janine Mertens-Rill; Martin Tegenthoff; Janice L Holton; Matthew B Harms; Thomas E Lloyd; Matthias Vorgerd; Conrad C Weihl; Katrin Marcus; Rudolf A Kley
Journal:  Ann Neurol       Date:  2017-01-27       Impact factor: 10.422

3.  Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.

Authors:  Jerry R Mendell; Zarife Sahenk; Samiah Al-Zaidy; Louise R Rodino-Klapac; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Natalie Miller; Mehmet Yalvac; Igor Dvorchik; Melissa Moore-Clingenpeel; Kevin M Flanigan; Kathleen Church; Kim Shontz; Choumpree Curry; Sarah Lewis; Markus McColly; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

4.  Immunotherapy of inflammatory myopathies: practical approach and future prospects.

Authors:  Marinos C Dalakas
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 5.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 6.  Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.

Authors:  Marinos C Dalakas
Journal:  J Clin Immunol       Date:  2014-04-11       Impact factor: 8.317

Review 7.  Diagnosis, pathogenesis and treatment of myositis: recent advances.

Authors:  P-O Carstens; J Schmidt
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

8.  Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.

Authors:  Julia V Wanschitz; Odile Dubourg; Emmanuelle Lacene; Michael B Fischer; Romana Höftberger; Herbert Budka; Norma B Romero; Bruno Eymard; Serge Herson; Gillian S Butler-Browne; Thomas Voit; Olivier Benveniste
Journal:  Neuromuscul Disord       Date:  2012-10-09       Impact factor: 4.296

Review 9.  Theories of the pathogenesis of inclusion body myositis.

Authors:  Steven A Greenberg
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.686

10.  Cell stress molecules in the skeletal muscle of GNE myopathy.

Authors:  Charlotte Fischer; Konstanze Kleinschnitz; Arne Wrede; Ingrid Muth; Niels Kruse; Ichizo Nishino; Jens Schmidt
Journal:  BMC Neurol       Date:  2013-03-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.